DAX-2,31 % EUR/USD-0,09 % Gold+0,55 % Öl (Brent)-2,91 %
NewsFlashAnzeige
Was steckt hinter diesem 355% Kursgewinn? Unfassbares Zukunftspotential!

Ocular Therapeutix Chart

Neuigkeiten zur Ocular Therapeutix Inc Aktie

ZeitTitel
SmartbrokerAlles für nur 4 Euro pro Order handeln. Dauerhaft - Jetzt auf smartbroker.de Anzeige
26.11.19

Ocular Therapeutix to Present at the Piper Jaffray 31st Annual Healthcare Conference
14.11.19

Ocular Therapeutix to Present at the Jefferies 2019 London Healthcare Conference
12.11.19

Ocular Therapeutix Reports Third Quarter 2019 Financial Results and Business Update
08.11.19

Ocular Therapeutix Announces Strategic Update and Operational Restructuring
05.11.19

Ocular Therapeutix To Report Third Quarter 2019 Financial Results
05.11.19

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01.10.19

Ocular Therapeutix Announces Permanent J-Code for DEXTENZA (dexamethasone ophthalmic insert) Effective October 1, 2019
26.09.19

Ocular Therapeutix to Present at the 2019 Cantor Global Healthcare Conference
24.09.19

Ocular Therapeutix Announces First Patient Dosed in Phase 3 Clinical Trial of DEXTENZA for the Treatment of Allergic Conjunctivitis
29.08.19

Ocular Therapeutix to Present at the 2019 Wells Fargo Healthcare Conference
07.08.19

Ocular Therapeutix Reports Second Quarter 2019 Financial Results and Business Update
01.08.19

Ocular Therapeutix To Report Second Quarter 2019 Financial Results
26.07.19

Ocular Therapeutix Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services
11.07.19

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Die neusten Nachrichten zu Ocular Therapeutix

ZeitTitel
26.11.19
Ocular Therapeutix to Present at the Piper Jaffray 31st Annual Healthcare Conference
14.11.19
Ocular Therapeutix to Present at the Jefferies 2019 London Healthcare Conference
12.11.19
Ocular Therapeutix Reports Third Quarter 2019 Financial Results and Business Update
08.11.19
Ocular Therapeutix Announces Strategic Update and Operational Restructuring
05.11.19
Ocular Therapeutix To Report Third Quarter 2019 Financial Results
mehr Ocular Therapeutix Nachrichten »

Nachrichten aus der Branche Pharmaindustrie

ZeitTitel
15:36 Uhr
Roche: Verlässlicher Dividendenzahler - Aktienanalyse
15:17 Uhr
Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak
15:00 Uhr
Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic Surgery
14:45 Uhr
Smart Cannabis Corp’s (SCNA) new Budding Botanicals acquisition offers exciting line of CBD and Hemp Products
14:30 Uhr
Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti
mehr Branchennachrichten »

Indexzugehörigkeit von Ocular Therapeutix

WertpapierPerf. %
Nasdaq
-0,93
Russell 2000 (calculated by Bridge Data Services)
0,00
NASDAQ Global Market Composite Index
-1,31
Nasdaq DM Ex Korea Small Cap CAD Index
-0,68
NASDAQ Health Care Index
-2,17
Nasdaq DM Ex Korea Small Cap JPY Index Net Total Return
-0,57
NASDAQ OMX NASDAQ Composite Total Return Index
-0,93
Nasdaq DM Ex Korea Small Cap GBP Index Net Total Return
-0,23
Nasdaq DM Ex Korea Small Cap EUR Index Net Total Return
-0,44
Alle zugehörigen Indizes »

Aktienkurs Ocular Therapeutix A1180P |

BörsenplatzNYSE
Letzter Kurs4,530USD
Performance-3,41 %
Kurszeit25.01.20
Eröffnung4,530USD
Tageshoch4,530USD
Tagestief4,530USD
Vortageskurs4,690USD
52-Wochen Hoch5,330USD
52-Wochen Tief2,460USD
Performance 1 Monat-0,42 %
Performance 1 Jahr+30,46 %

Stammdaten zu Ocular Therapeutix

NameOcular Therapeutix Inc
KurznameOcular Therap
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA1180P
SymbolOCUL
BranchePharmaindustrie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl48,08 Mio.
Marktkapitalisierung217,80 Mio.USD

Performance Ocular Therapeutix Aktie

ZeitKursPerf.
1 Tag4,530USD
-3,41 %
1 Woche4,600USD
+1,96 %
1 Monat4,710USD
-0,42 %
3 Monate3,420USD
+37,13 %
6 Monate4,580USD
+2,40 %
Lfd. Jahr3,950USD
+18,73 %
1 Jahr3,595USD
+30,46 %
3 Jahre6,880USD
-31,83 %
5 Jahre26,35USD
-82,20 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameOcular Therapeutix Inc
StadtBedford, MA
LandUSA USA
Webseitewww.ocutx.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Sernova
+2,94
2.
IntelGenx Technologies
-0,77
3.
AEterna Zentaris
-9,02
4.
Kitov Pharma
-3,53
5.
Teligent
-6,16
6.
CannaRoyalty
+0,80
7.
Achieve Life Sciences
-3,62
8.
IVERIC bio
+3,70
9.
DelMar Pharmaceuticals
-4,56
10.
Tetraphase Pharmaceuticals
-3,03

Emissionsinformationen

Emissionspreis13,000USD
Emissionsvolumen5.000.000Stück
ZeichnungsgebührNein
IPO Anmeldetag20.06.2014
IPO25.07.2014
PlatzierungÖffentlich

Handelsinformationen

Handelszeit16:01 - 20:05 Uhr
Liquidister HandelsplatzNasdaq